13-pregnancy & Dm

  • Uploaded by: api-3703352
  • 0
  • 0
  • July 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View 13-pregnancy & Dm as PDF for free.

More details

  • Words: 1,990
  • Pages: 50
DIABETES & PREGNANCY

JEHAD AL-HARMI DEPARTMENT OF OBS & GYN FACULTY OF MEDICINE/ KUWAIT UNIVERSITY

DEFINITION • Persistent state of hyperglycemia due to lack, or diminished effectiveness, of endogenous insulin • Very common medical complication of pregnancy; variable incidence from 0.5 – 15%

TYPES-1 Abnormal glucose metabolism in pregnancy: 1. Overt, pregestational, or pre-existing DM 2. Gestational diabetes (GDM): • • • •

First diagnosed during pregnancy May persist after delivery May include a small group of overt DM Has many similarities to NIDDM

1. Impaired glucose tolerance test (IGTT)

TYPES-2 Pregestational DM: 1. Type I or IDDM: • •

Usually juvenile onset May be associated with autoimmune disease

1. Type II or NIDDM: • • •

Usually adult onset Occurs more frequently in the obese Has a stronger familial component

CLASSIFICATION MODIFIED WHITE CLASSIFICATION:         

A1 A2 B C D F R H T

GDM on diet GDM on insulin Onset after age 20 years, or duration less than Onset &/or duration between 10-20 years Onset before age 10 years, or duration more Nephropathy Proliferative (not background) retinopathy Coronary artery disease Renal transplant

10 years than 20 years

RISK FACTORS-1 WHAT ARE THE RISK FACTORS OF GDM?

RISK FACTORS-2 1. Family h/o DM (1st degree relative) 2. Previous h/o GDM – Recurrence rate is 60-70%. Why not 100%? What are the predictors?

3. Glycosuria – Before 16/52 – >2 occasions

4. Polyhydramnios (AFI > 25 cm)

RISK FACTORS-3 5. Age > 30 years 6. Obesity (BMI > 27 kg/m²) 7. Polyuria 8. Polydypsia 9. Excessive weight gain (> 18 kg)

RISK FACTORS-4 10. Previous h/o: 1. Recurrent spontaneous abortions 2. Unexplained SB or NND 3. Baby with major congenital anomalies (CNS, cardiac, skeletal) 4. Big baby (> 4500 g) 5. Recurrent PE 6. Recurrent candidaiasis

DIAGNOSIS - 1 SCREENING: – Why? – Whom? – How? – When?

DIAGNOSIS - 2 SCREENING: • Glucose loading/challenge test (GLT): – No special preparation – 50 g glucose; measure plasma BS after 1 hour – For low-risk: screen at 26-28/52 – For high-risk: screen at booking & if result negative repeat at 26-28/52

DIAGNOSIS - 3 • If GLT > 10 or FBS > 7.2 mmol/l no need for further testing; patient is diabetic • If GLT 7.3-10 mmol/l proceed to oral glucose tolerance test (OGTT)

OGTT – 3 days on diet containing 150 g CHO daily – Fasting 8 - 14 hours. 100 g glucose load – Measure plasma levels – No smoking or excessive activity

• Normal values: – FBS –1h –2h –3h

5.3 mmol/l 10 1 high value = IGTT 8.6 2 high values = GDM 7.8

GLUCOSE METABOLISM IN PREGNANCY • GLYCOSURIA: – Often seen during pregnancy due to ↓ renal threshold of glucose excretion & incomplete reabsorption in the renal tubules

• GLYCEMIA: – FBS usually lower by 0.5 mmol/l; PPBS higher – Higher highs & lower lows

EFFECTS OF DIABETES ON PREGNANCY - 1 WHAT ARE THE MATERNAL COMPLICATIONS OF DM?

EFFECTS OF DIABETES ON PREGNANCY - 2 MATERNAL - 1: 1. DKA  fetal & / or maternal death 2. Hypoglycemia (if severe & prolonged) may lead to fetal death. But usually better tolerated than hyperglycemia 3. Polyhydramnios  PROM, & unstable lie 4. PET especially in presence of renal impairment (20-40%, up to 60%)

EFFECTS OF DIABETES ON PREGNANCY - 3 MATERNAL - 2: 5. Macrosomia (25% of IDM have BW >4000 grams; 60% are LGA with BW >90th percentile) CPD, operative delivery, shoulder dystocia, trauma, & PPH 6. UTI & pyelonephritis 7. Vulvovaginal candidaiasis

EFFECTS OF DIABETES ON PREGNANCY - 4 WHAT ARE THE FETAL/NEONATAL COMPLICATIONS OF DM?

EFFECTS OF DIABETES ON PREGNANCY - 5 FETAL & NEONATAL - 1: 1. Spontaneous abortion 2. Macrosomia  shoulder dystocia  asphyxia &/or trauma 1. Erb’s palsy, Klumpke’s palsy 2. Facial palsy, Horner’s syndrome 3. Clavicular or humeral fractures

3. IUFD in late pregnancy 4. Prematurity (double)

EFFECTS OF DIABETES ON PREGNANCY - 6 FETAL & NEONATAL - 2: 5. FD during labor; secondary to acute & chronic hypoxia 6. Hypoglycemia especially in 1st 48 hours after delivery • Maternal hyperglycemia  fetal hyperglycemia  fetal hyperinsulinemia  hyperplasia & hypertrophy of fetal pancreatic islets of Langerhans  neonatal hypoglycemia (Pederson hypothesis) • Check RBS frequently and start early feeding

EFFECTS OF DIABETES ON PRGNANCY - 7 FETAL & NEONATAL - 3: 7. RDS or HMD 8. Hypocalcemia 9. Polycythemia & neonatal jaundice 10. Congenital anomalies: 1. 2. 3. 4.

Sacral agenesis & caudal regression CNS : open NTD. Role of folic acid? CVS : TOGV, VSD, ASD Renal

INFANT OF DIABETIC MOTHER

EFFECTS OF PREGNANCY ON DIABETES • NIDDM patients will require insulin because oral hypoglycemic agents relatively contraindicated. Why? • IDDM patients will require higher doses of insulin • Existing retinopathy & nephropathy may worsen

PROGNOSIS-1 • PNM associated with DM has decreased 10 X in the past 40 years because of better glycemic control, reduction of early IOL, & advances in neonatal care • Benefits of tight glycemic control: – Early pregnancy: decrease possibility of abortions & fetal anomalies – Later pregnancy: decrease the rate of macrosomia & PNM

PROGNOSIS-2 RULE OF 15: – 36% of women with GDM develop DM within 15 years – 15% of pregnant patients have abnormal GLT – 15 % of those have abnormal OGTT – 15 % of those require insulin therapy – 15% of patients with GDM have macrosomic babies (BW> 4000 grams)

MANAGEMENT - 1 PRECONCEPTION COUNSELING - 1: – Timing of pregnancy & importance of Hb A1c levels in detecting control over the past 30-40 days • Hb A1c produced by slow glycosylation • Normal range 3-4% • If level > 12% associated with increased risk of complications

– Postponement of pregnancy till later age not advisable. Why?

MANAGEMENT - 2 PRECONCEPTION COUNSELING - 2: – Re-education – Ideal control: • Glucose home monitoring by capillary sampling • Patient injects herself with insulin • Close relatives able to deal with emergencies

– Long-term effects on off-spring: • Childhood obesity • Early-onset type II DM

MANAGEMENT - 3 ANC - 1: – Team approach (obstetrician, physician, nurse, dietician) – Additional testing: • RFT, 24-hour urine collection for total protein & creatinine clearance rate • Fundoscopy • MSU for C&S • Fetal echocardiography

MANAGEMENT - 4 ANC - 2: – Insulin dose & frequency may have to be increased (up to 2-3 X in later pregnancy) – Glucose home monitoring (as opposed to repeated hospital admissions) increases compliance, improves results, & reduces cost – Visits every 2/52 till 32/52, then weekly till delivery

MANAGEMENT - 5 ANC - 3: – U/S in T1 for viability & confirmation of GA – U/S at 20-24/52 for anomalies – U/S at 32-36/52 for growth – Daily FKC starting at 32/52 – Weekly NST starting at 32/52; increase to twice weekly at 34-36/52 – Weekly BPP may also be carried out

MANAGEMENT - 6 GDM: – Diabetic diet for 1/52 – BSP: 7 readings – If controlled with diet, recheck FBS & PPBS every 1-2/52 – If insulin is needed, admit to hospital

MANAGEMENT - 7 DIET: – 30-35 kcal/kg of ideal body weight (range = 1800-2800 kcal/ day) – 3 meals + 3 snacks – 50 % CHO (complex & high fiber) + 30 % fat + 20 % protein – 25 % breakfast + 30 % lunch & dinner + 5 % each snack – Consistency in dietary intake and activity level

MANAGEMENT - 8 INSULIN THERAPY - 1: – If initial FBS > 9 mmol/l – If diet does not provide satisfactory control within 1-2/52 • • • • •

FBS < 5.3 mmol/l Pre-prandial < 6 THIS IS 1-hour PPBS < 7.8 “TIGHT GLYCEMIC 2-hour PPBS < 6.7 CONTROL” Not less than 4

MANAGEMENT - 9 INSULIN THERAPY - 2: – Total dose: • T1  0.5 units/kg actual body weight • T2  0.6 • T3  0.7

– Dose divided into 2/3 in am + 1/3 in pm – AM dose further divided into 1/3 short-acting + 2/3 intermediate- acting – PM dose divided in 1/2

MANAGEMENT - 10 INSULIN THERAPY - 3: – Alternative regimen: • 3 pre-prandial doses of short-acting insulin • 1 dose of intermediate-acting insulin at bedtime if FBS high

– Reduced compliance but better glycemic control – What is the role of continuous subcutaneous insulin infusion pumps?

MANAGEMENT - 11 INSULIN THERAPY - 4: – HR / Actrapid: • Onset of action after 30 minutes • Peak effect within 2 hours

– HN / Monotard: • Onset of action after 2 hours • Peak action within 10 hours

MANAGEMENT - 12 JAMEELA – 24 year old – G1 – GA = 26/5 – GLT = 11 mmol/l – Weight = 100 kg

MANAGEMENT - 13 • IGTT: – Repeat OGTT after 4/52 if test was done before 28/52 – Dietary advice; especially for those with high FBS. Occasional FBS & PPBS – FKC & NST as for normal pregnancy

• Others: – Oral hypoglycemic drugs (Glyburide) – Exercise (upper body CV training)

MANAGEMENT - 14 LABOR & DELIVERY - 1: – DM on insulin IOL at 38-39/52 – GDM A1 IOL at 40/52 – IGTT IOL at 41-42/52 (overdue ) – Aim for vaginal delivery. But LCSC rates are higher for diabetics (up to 60%) because of FD & macrosomia

MANAGEMENT - 15 LABOR & DELIVERY - 2: – On day of delivery: • Reduce am dose of intermediate-acting insulin (1/3-1/2 usual dose) • Start IV fluids D5% in NS at 125 cc/h • RBS 1-2 hourly. Check urine each void for glucose & ketones • Start IV insulin if RBS > 6.7 mmol/l • Continuos FHR monitoring • Pediatrician to examine baby after delivery

MANAGEMENT - 16 PNC - 1: – Insulin requirements decrease after delivery – GDM A1  normal diet, FBS & PPBS after 2 days. 75-gram, 2-hour OGTT 6/52 later – GDM A2  diabetic diet, BSP after 2 days, OGTT 6/52 later

MANAGEMENT - 17 PNC - 2: – 5-20% of GDM patients continue to have DM after delivery – Pre-existing diabetics can go back to prepregnancy regimen

MANAGEMENT - 18 PNC - 3: – Breast-feeding should be encouraged; take into account increased caloric demand. How much? – 30-50% of patients with GDM develop type II DM within 20 years; especially if obese – Diabetogenic effect of pregnancy increased by repeated pregnancies & obesity

MANAGEMENT - 19 FAMILY PLANNING: – Advice regarding limiting size of family in presence of retinopathy or nephropathy – Low-dose OCP if young, non-obese, & normotensive – IUCD – Barrier methods – Sterilization

CASE - 1 SALMA – 22 year old lady. MF 2/12 – IDDM since the age of 9 years – Had renal transplant last year – Attends for pre-conceptual counseling – Outline management

CASE - 2 NADIA – 30 year old lady. MF 5 years – G6 P0+2+3+2. Previous LSCS X 2 – IDDM since the age of 22 years – GA = 6/52 – Attends for her booking ANC visit – Outline management

CASE - 3 FAWZIA – 40 year old lady. MF 18 years – G7 P5+1+0+7. Previous LSCS – GDM on insulin – GA = 37/52. Breech presentation – EFW by U/S +/- 4000 g – Outline management

CASE - 4 NAEEMA – 30 year old lady. MF 5 years – Juvenile DM. G6 P2+0+3+2 – G 4: LSCS for failed VE. BW = 3700g – G 5: VBAC. BW = 3200g – GA = 37/52. SFH = 42 cm. EFW = 4000g. Hb A1c = 12% – Outline plan for delivery

CASE - 5 RIHAB – 22 year old lady. MF 1 year – G1 P1+0+0+1 – Delivered 3 days ago. FTND after IOL for GDM A1. BW = 3200 g – She plans to breast-feed her baby – She seeks contraceptive advice

THE END

Related Documents

13-pregnancy & Dm
July 2020 7
Dm
November 2019 48
Dm
October 2019 53
Dm
June 2020 31
Dm
July 2020 23
Dm
October 2019 55